2BB score and signals
Tenax Therapeutics, Inc.’s current 2BB score is 30 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 20 | Low |
| Momentum | 34 | Weakening |
| Financial strength | 28 | Weak |
| Quality | 40 | Normal |
| Risk | 44 | Moderate |
Company facts
| CEO | Chris Giordano |
| Founded | 1967 |
| Employees | 15 |
| 52-week range | $1.31 – $19.40 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.3672 | — | $0.00 |
| 2026-08-11 | — | -0.3687 | — | $0.00 |
| 2026-05-12 | -0.35 | -0.408 | $0.00 | $0.00 |
| 2026-03-10 | -0.38 | -0.4233 | $0.00 | $0.00 |
Related companies
